Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
16.3M
-
Shares change
-
-789K
-
Total reported value, excl. options
-
$276M
-
Value change
-
-$14.2M
-
Put/Call ratio
-
0.14
-
Number of buys
-
83
-
Number of sells
-
-84
-
Price
-
$16.90
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q1 2025
215 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.3M shares
of 30.2M outstanding shares and own 54.01% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.24M shares), MILLENNIUM MANAGEMENT LLC (1.97M shares), VANGUARD GROUP INC (1.17M shares), DIMENSIONAL FUND ADVISORS LP (1.03M shares), ACADIAN ASSET MANAGEMENT LLC (806K shares), AMERIPRISE FINANCIAL INC (625K shares), STATE STREET CORP (507K shares), GEODE CAPITAL MANAGEMENT, LLC (505K shares), Park West Asset Management LLC (448K shares), and D. E. Shaw & Co., Inc. (440K shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.